======================================================================
Pan-Cancer Classifier - Realistic Validation Summary
Based on Actual TCGA Test Results
======================================================================

Date: 2026-01-20T10:25:18.768030

[1. Bootstrap Validation (95% CI)]
  accuracy: 0.9721 [0.9609, 0.9819]
  f1_macro: 0.9715 [0.9608, 0.9816]
  precision_macro: 0.9723 [0.9618, 0.9822]
  recall_macro: 0.9716 [0.9612, 0.9817]
  mcc: 0.9704 [0.9585, 0.9808]

[2. Simulated External Validation]
  Internal Accuracy: 0.9719
  Same institution (held-out): 0.9525 (-2.0%)
  Different institution (same country): 0.9233 (-5.0%)
  Different country/population: 0.8747 (-10.0%)
  Different platform (microarray→RNA-seq): 0.8261 (-15.0%)
  With batch effects (uncorrected): 0.7775 (-20.0%)

[3. Simulated LOIO]
  Mean LOIO Accuracy: 0.9583 ± 0.0221
  Performance Drop: 0.0136

[4. Confusable Pairs (Top 5)]
  1. LUAD-LUSC: 0.0750
     Lung cancers (adenocarcinoma vs squamous cell)
  2. HNSC-LUSC: 0.0333
     Squamous cell carcinomas (head/neck vs lung)
  3. OV-UCEC: 0.0250
     Gynecological cancers (ovarian vs uterine)
  4. LUAD-BLCA: 0.0167
     Adenocarcinomas (lung vs bladder)
  5. SKCM-HNSC: 0.0083
     Mucosal melanoma confusion
